Taconic Biosciences Expands European Immunodeficient Animal Production
HUDSON, NY--(Marketwired - Jan 12, 2017) - Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced that effective January 16, 2017, the company has begun production of commercial animals in its Cologne, Germany facility. Taconic offers rodent models at a variety of health status options. This decision comes in response to increased industry demand for mouse models at more restrictive flora statuses. A key facet of Taconic's global quality program is harmonization among all commercial facilities. The Cologne site will utilize the same strict processes and standards employed at other Taconic locations, including stringent genetic and health controls. Gnotobiotic animals produced in Cologne will meet the Excluded Flora (EF) health standard , frequently used in immunology, oncology, and microbiome research.
"Taconic is expanding our production facilities in response to growing demand for our genetically engineered models (GEMs) and services. These state of the art facilities utilize individually ventilated cages (IVCs) to support our desire to offer consistent animals with clearly defined health and genetic characteristics. As our European business expands, we expect to add new models and capabilities to the Cologne location," said Dr. Robert Rosenthal, chief executive officer of Taconic Biosciences. Two popular Taconic strains, the CIEA NOG mouse® and hGM-CSF/hIL3-NOG , will be available for delivery starting the week of January 16, 2017, with additional strains added in the future.
The Cologne site has over twenty years' experience designing custom transgenic models for leading pharmaceutical, biotech, and academic clients. Taconic Biosciences is fully licensed to utilize CRISPR/Cas9, homologous recombination and other technologies to develop custom mouse and rat models, including humanized, knockout, knock-in, inducible shRNA, or microRNA expressing models.
To learn more, please contact Taconic Biosciences at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe or at firstname.lastname@example.org
About Taconic Biosciences, Inc. Taconic Biosciences is a global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Information om Marketwired
Følg pressemeddelelser fra Marketwired
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Marketwired
Silexica16.1.2018 14:31 | pressemeddelelse
Silexica partners with Fujitsu on next-generation base station projects
Banque Fédérative du Credit Mutuel SA10.1.2018 11:57 | pressemeddelelse
Banque Federative du Credit Mutuel SA: Pre Stabilisation Notice
Librestream Technologies Inc.4.1.2018 18:01 | pressemeddelelse
Librestream Advances its Onsight Platform with Expanded Content Management and AR Capabilities
Bombardier Transportation3.1.2018 16:01 | pressemeddelelse
Bombardier to Provide 54 Additional TWINDEXX Vario Double-Deck Coaches to Israel Railways
Bombardier Transportation28.12.2017 14:09 | pressemeddelelse
Bombardier to Provide 40 TRAXX Locomotives and Long-Term Fleet Maintenance to TX Logistik
Bombardier Inc.27.12.2017 16:41 | pressemeddelelse
Bombardier Completes Redemption of its 4.75% Senior Notes due 2019
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum